ViiV expands licensing deal for its HIV drug in low-income countries The initial agreement covered HIV prevention, but will now also include treatment

https://www.statnews.com/pharmalot/2025/07/15/gsk-viiv-aids-hiv-gilead-cabotegravir-lenacapavir-patents-medicine-prevention-treatment-who/